PROGRESS-Study

Study design
Prospective, longitudinal, multi-center case control study on progression of community acquired pneumonia with material collecting for genomic, transcriptomic and proteomic analysis.

Start
Recruiting started in august 2009

Study population

CAP-Patients with different severities of disease
(uCAP - sCAP - ssCAP)
 
Number of patients
N~3000 analyzable patients
 

Goals
- Identify genetic and molecular markers (DNA, RNA, Proteins)
- Prediction of a severe course of disease
- Improved understanding of underlying processes

Perspective
Improved clinical management of CAP and complications